Automating Cell Line Development for Biotherapeutics
Cell Line Development (CLD) lies at the heart of producing effective biotherapeutics. Monoclonal antibodies (mAbs), bi- and trispecific antibodies, and antibody-drug conjugates are transforming cancer and autoimmune disease treatments. These therapeutic antibodies originate from engineered producer cell lines. However, the process of developing these cell lines is intricate and multifaceted.
Here’s how Beckman Coulter’s automation solutions help you to accelerate your CLD workflow:
1. Understanding the Challenge:
CLD involves a series of steps, each
with its own complexities. From cell line selection to optimization, automation
streamlines the entire process.
2. Beckman Coulter’s Core Role:
Our automated liquid handlers play a pivotal role in CLD. These systems are designed to handle critical tasks efficiently, ensuring reproducibility and high-quality results.
3
.
Versatile & modular solutions
Echo Acoustic Liquid Handlers:
These cutting-edge systems offer precise, non-contact liquid handling. They excel in transferring small volumes, minimizing sample loss, and enhancing throughput.
Biomek i-Series i5 and i7:
These workstations provide flexibility. Whether you’re working on specific steps or need an integrated solution, Biomek i-Series adapts to your requirements.
Benefits of Beckman Coulter’s CLD Automation:
- Speed: Automated workflows significantly reduce processing time, allowing faster cell line development.
- Consistency: Minimized human intervention ensures consistent results across experiments.
- Data Tracking: Comprehensive workflow data is tracked seamlessly, aiding analysis and optimization.
- Expertise: Beckman Coulter understands the challenges of CLD, making our solutions tailored to your needs.
Listen to Beckman Coulter Expert: Cell line development and synbio workflows driven by automation
In summary, Beckman Coulter’s automation expertise empowers researchers to overcome CLD challenges efficiently.
Discuss your specific requirements with our experts and let us enhance your biotherapeutic development journey.
Ask our experts
